Clinical Trial Update: Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating taladegib with paclitaxel, carboplatin, and radiation therapy for localized esophageal or gastroesophageal junction cancer; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• taladegib (taladegib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gastroesophageal Junction Adenocarcinoma, Stage IB Esophageal Adenocarcinoma AJCC v7 | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-07-10